More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.66B
EPS
0.13
P/E ratio
169.1
Price to sales
1.32
Dividend yield
--
Beta
0.831678
Previous close
$21.99
Today's open
$21.95
Day's range
$21.55 - $22.05
52 week range
$18.77 - $26.51
show more
CEO
Parth Mehrotra
Employees
1140
Headquarters
Arlington, VA
Exchange
Nasdaq Global Select
Shares outstanding
123001529
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26
ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026.
GlobeNewsWire • Jan 22, 2026

3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
Three Healthcare IT stocks have surged over 20% in 2025, driven by growth in telehealth, remote monitoring and value-based care platforms.
Zacks Investment Research • Dec 23, 2025

Privia Health Group, Inc. (PRVA) Q3 2025 Earnings Call Transcript
Privia Health Group, Inc. ( PRVA ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Robert Borchert - Senior Vice President of Investor Relations & Corporate Communications Parth Mehrotra - CEO & Director David Mountcastle - Executive VP, CFO & Principal Accounting Officer Conference Call Participants Marco Criscuolo - Nephron Research LLC Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Thomas Walsh - Barclays Bank PLC, Research Division Matthew Shea - Needham & Company, LLC, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Jeffrey Garro - Stephens Inc., Research Division Ryan Langston - TD Cowen, Research Division Albert Rice - UBS Investment Bank, Research Division Constantine Davides - Citizens JMP Securities, LLC, Research Division Derek Gross - Piper Sandler & Co., Research Division Daniel Grosslight - Citigroup Inc., Research Division Jack Slevin - Jefferies LLC, Research Division Jenny Shen - BTIG, LLC, Research Division Ryan Daniels - William Blair & Company L.L.C., Research Division Presentation Operator Hello, and welcome to the Privia Health Third Quarter 2025 Results Conference Call.
Seeking Alpha • Nov 6, 2025

Privia Health Reports Third Quarter 2025 Financial Results
Privia Health Reports Very Strong Q3 and YTD Results Across the Business; FY'25 Guidance Raised Above High End for All Key Operating and Financial Metrics
GlobeNewsWire • Nov 6, 2025

Here's What Key Metrics Tell Us About Privia Health (PRVA) Q3 Earnings
The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 6, 2025

Privia Health (PRVA) Lags Q3 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.03 per share a year ago.
Zacks Investment Research • Nov 6, 2025

Privia Health's Premium: A Breakout Play
Privia Health Group offers high-growth potential with a recurring revenue model and strong relationships, making it attractive amid the healthcare sector underperformance. PRVA's recent acquisition of Evolent Health's ACO adds over 120,000 users, boosting revenue streams and raising expectations for the next earnings report. Despite a high forward P/E and a DCF model suggesting downside, technical patterns and sector comps support a potential breakout above $26, targeting $28–$36.
Seeking Alpha • Oct 31, 2025

Privia Health to Report Third Quarter 2025 Results on Thursday, November 6
ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2025 before market open on Thursday, November 6, 2025.
GlobeNewsWire • Oct 7, 2025

Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care
Privia Health Group, Inc. PRVA on Tuesday agreed to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. EVH.
Benzinga • Sep 24, 2025

Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE: EVH).
GlobeNewsWire • Sep 23, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Privia Health Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.